跳至主要内容
临床试验/CTRI/2025/09/094674
CTRI/2025/09/094674尚未招募不适用

Therapeutic potential of Natural polyphenol-Resveratrol in Premalignant oral lesions-A Randomised Controlled Study”

Not applicable1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
• Change in lesion size and clinical appearance.

研究概览

简要总结

Title of the Study/Project : Therapeutic potential of resveratrol in PMD, a randomised

Resveratrol , a natural polyphenol , exhibits anti-inflammatory , antioxidant and

wound healing properties by modulating cytokines and oxidative stress .

Preclinical studies support its role in enhancing tissue repair but clinical evidence i

oral surgery is limited .

clinical evidence supporting the use of Resveratrol in the treatment of oral

premalignant lesions remains limited, with few well-designed randomized controlle

trials evaluating its therapeutic potential.

This study aims to fill this gap by rigorously assessing the clinical and

histopathological effects of Resveratrol in patients with oral premalignant lesions

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Male

入选标准

  • 1 Adults aged 18–70 years 2 Histologically confirmed OPLs (e.g.leukoplakia, oral epithelial dysplasia) 3 Lesion size should be more than or equal to 1cm 4 No prior treatment for the current lesion.
  • 5 Willingness to comply with study procedures and provide informed consent.

排除标准

  • 1 Malignant oral lesions 2 Severe systemic conditions or immunocompromised status 3 Pregnancy or lactation 4 Known hypersensitivity to resveratrol 5 Concurrent use of other chemopreventive agents.

结局指标

主要结局

• Change in lesion size and clinical appearance.

时间窗: Duration of study - 12 months

• Histopathological assessment of dysplasia grade.

时间窗: Duration of study - 12 months

次要结局

  • • Patient-reported pain & discomfort scores.(• Incidence of adverse events.)

研究者

发起方
Not applicable
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr nitin bhagat

Manav rachna dental college

研究点 (1)

Loading locations...

相似试验